Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19.

Giuseppe GrittiFederico RaimondiBarbara BottazziDiego RipamontiIvano RivaFrancesco LandiLeonardo AlborghettiMarco FrigeniMarianna DamianiCaterina MicòStefano FagiuoliFerdinando Luca LoriniLucia GandiniLuca NovelliJonathan P MorganBenjamin M J OwensKaran J K KanhaiGordana Tonkovic ReljanovicMarco RizziFederico RaimondiAlberto MantovaniAlessandro Rambaldi

Published in: Leukemia (2021)

Keyphrases

coronavirus disease
sars cov
early onset
free survival
respiratory syndrome coronavirus
drug induced